{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T19:06:50Z","timestamp":1784401610488,"version":"3.55.0"},"reference-count":68,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T00:00:00Z","timestamp":1704931200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["MEXT"],"award-info":[{"award-number":["MEXT"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Patients with coronavirus disease-2019 (COVID-19) have an increased risk of thrombosis and acute respiratory distress syndrome (ARDS). Thrombosis is often attributed to increases in plasminogen activator inhibitor-1 (PAI-1) and a shut-down of fibrinolysis (blood clot dissolution). Decreased urokinase-type plasminogen activator (uPA), a protease necessary for cell-associated plasmin generation, and increased tissue-type plasminogen activator (tPA) and PAI-1 levels have been reported in COVID-19 patients. Because these factors can occur in free and complexed forms with differences in their biological functions, we examined the predictive impact of uPA, tPA, and PAI-1 in their free forms and complexes as a biomarker for COVID-19 severity and the development of ARDS. In this retrospective study of 69 Japanese adults hospitalized with COVID-19 and 20 healthy donors, we found elevated free, non-complexed PAI-1 antigen, low circulating uPA, and uPA\/PAI-1 but not tPA\/PAI-1 complex levels to be associated with COVID-19 severity and ARDS development. This biomarker profile was typical for patients in the complicated phase. Lack of PAI-1 activity in circulation despite free, non-complexed PAI-1 protein and plasmin\/\u03b12anti-plasmin complex correlated with suPAR and sVCAM levels, markers indicating endothelial dysfunction. Furthermore, uPA\/PAI-1 complex levels positively correlated with TNF\u03b1, a cytokine reported to trigger inflammatory cell death and tissue damage. Those levels also positively correlated with lymphopenia and the pro-inflammatory factors interleukin1\u03b2 (IL1\u03b2), IL6, and C-reactive protein, markers associated with the anti-viral inflammatory response. These findings argue for using uPA and uPA\/PAI-1 as novel biomarkers to detect patients at risk of developing severe COVID-19, including ARDS.<\/jats:p>","DOI":"10.3389\/fimmu.2023.1299792","type":"journal-article","created":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T10:05:55Z","timestamp":1704967555000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["Urokinase-type plasminogen activator and plasminogen activator inhibitor-1 complex as a serum biomarker for COVID-19"],"prefix":"10.3389","volume":"14","author":[{"given":"Tetiana","family":"Yatsenko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Rios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiane","family":"Nogueira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yousef","family":"Salama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoko","family":"Tabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshio","family":"Naito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhisa","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Hattori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beate","family":"Heissig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,1,11]]},"reference":[{"key":"B1","doi-asserted-by":"crossref","DOI":"10.1038\/s41577-022-00762-9","article-title":"Understanding COVID-19-associated coagulopathy","volume-title":"Nat Rev Immunol","author":"Conway","year":"2022"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020003083","article-title":"Frequency of venous thromboembolism in 6513 patients with COVID-19: a retrospective study","volume":"4","author":"Hill","year":"2020","journal-title":"Blood Adv"},{"key":"B3","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/s41569-020-00469-1","article-title":"Thrombocytopathy and endotheliopathy: crucial contributors to COVID-19 thromboinflammation","volume":"18","author":"Gu","year":"2021","journal-title":"Nat Rev Cardiol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/j.jamcollsurg.2021.02.019","article-title":"Fibrinolysis shutdown in COVID-19: clinical manifestations, molecular mechanisms, and therapeutic implications","volume":"232","author":"Meizoso","year":"2021","journal-title":"J Am Coll Surg"},{"key":"B5","doi-asserted-by":"publisher","first-page":"2549","DOI":"10.3390\/biomedicines10102549","article-title":"COVID-19 severity and thrombo-inflammatory response linked to ethnicity","volume":"10","author":"Heissig","year":"2022","journal-title":"Biomedicines"},{"key":"B6","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.thromres.2022.02.008","article-title":"Deaths related to pulmonary embolism and cardiovascular events before and during the 2020 COVID-19 pandemic: An epidemiological analysis of data from an Italian high-risk area","volume":"212","author":"Voci","year":"2022","journal-title":"Thromb Res"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.120.314872","article-title":"Prevalence and outcomes of D-dimer elevation in hospitalized patients with COVID-19","volume":"40","author":"Berger","year":"2020","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.13738","article-title":"Evaluation of soluble fibrin monomer complex in patients in SARS-CoV-2 COVID-19 infection-associated coagulopathy","volume":"108","author":"Sridharan","year":"2022","journal-title":"Eur J Haematol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1253\/circj.CJ-21-0169","article-title":"Incidence and clinical features of venous thromboembolism in hospitalized patients with coronavirus disease 2019 (COVID-19) in Japan","volume":"85","author":"Yamashita","year":"2021","journal-title":"Circ J"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2020.06.013","article-title":"COVID-19 and pneumonia: a role for the uPA\/uPAR system","volume":"25","author":"D\u2019alonzo","year":"2020","journal-title":"Drug Discov Today"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1111\/jth.14872","article-title":"Fibrinolytic abnormalities in acute respiratory distress syndrome (ARDS) and versatility of thrombolytic drugs to treat COVID-19","volume":"18","author":"Whyte","year":"2020","journal-title":"J Thromb Haemost"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22031283","article-title":"The central role of fibrinolytic response in COVID-19-A hematologist\u2019s perspective","volume":"22","author":"Kwaan","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B13","doi-asserted-by":"publisher","first-page":"109761","DOI":"10.1016\/j.cellsig.2020.109761","article-title":"The multifaceted role of plasminogen in inflammation","volume":"75","author":"Heissig","year":"2020","journal-title":"Cell Signal"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3390\/cells12030445","article-title":"The role of the plasminogen\/plasmin system in inflammation of the oral cavity","volume":"12","author":"Yatsenko","year":"2023","journal-title":"Cells"},{"key":"B15","doi-asserted-by":"publisher","first-page":"8151","DOI":"10.3390\/ijms22052304","article-title":"The multifaceted role of plasminogen in cancer","volume":"22","author":"Heissig","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.653655","article-title":"A serpin with a finger in many PAIs: PAI-1\u2019s central function in thromboinflammation and cardiovascular disease","volume":"8","author":"Morrow","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2010.155788","article-title":"PAI-1 is an essential component of the pulmonary host response during Pseudomonas aeruginosa pneumonia in mice","volume":"66","author":"Goolaerts","year":"2011","journal-title":"Thorax"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-12-399659","article-title":"Inhibition of PAI-1 induces neutrophil-driven neoangiogenesis and promotes tissue regeneration via production of angiocrine factors in mice","volume":"119","author":"Tashiro","year":"2012","journal-title":"Blood"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1096\/fj.201600871RR","article-title":"Plasminogen activator inhibitor-1 regulates macrophage-dependent postoperative adhesion by enhancing EGF-HER1 signaling in mice","volume":"31","author":"Honjo","year":"2017","journal-title":"FASEB J"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1111\/jth.15016","article-title":"Hypofibrinolytic state and high thrombin generation may play a major role in SARS-COV2 associated thrombosis","volume":"18","author":"Nougier","year":"2020","journal-title":"J Thromb Haemost"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1918761117","article-title":"Unbiased proteomics identifies plasminogen activator inhibitor-1 as a negative regulator of endothelial nitric oxide synthase","volume":"117","author":"Garcia","year":"2020","journal-title":"Proc Natl Acad Sci"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V86.3.1056.1056","article-title":"The cleavage and inactivation of plasminogen activator inhibitor type 1 by neutrophil elastase: the evaluation of its physiologic relevance in fibrinolysis","volume":"86","author":"Wu","year":"1995","journal-title":"Blood"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1089\/nat.2013.0475","article-title":"Inhibition of PAI-1 antiproteolytic activity against tPA by RNA aptamers","volume":"24","author":"Damare","year":"2014","journal-title":"Nucleic Acid Ther"},{"key":"B24","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1002\/pro.2841","article-title":"Distinct encounter complexes of PAI-1 with plasminogen activators and vitronectin revealed by changes in the conformation and dynamics of the reactive center loop","volume":"25","author":"Qureshi","year":"2016","journal-title":"Protein Sci"},{"key":"B25","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1186\/gb-2006-7-5-216","article-title":"An overview of the serpin superfamily","volume":"7","author":"Law","year":"2006","journal-title":"Genome Biol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/sj.bjc.6600656","article-title":"Accumulation of uPA \u2013 PAI-1 complexes inside the tumour cells is associated with axillary nodal invasion in progesterone-receptor-positive early breast cancer","volume":"88","author":"Schneider","year":"2003","journal-title":"Br J Cancer"},{"key":"B27","article-title":"Prognostic importance of the uPa\/PAI-1 complex in breast cancer","volume":"21","author":"Sten-Linder","year":"2001","journal-title":"Anticancer Res"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.5847\/wjem.j.1920-8642.2011.03.005","article-title":"Prognostic significance of urokinase-type plasminogen activator and its receptor in patients with systemic inflammatory response syndrome","volume":"2","author":"Yu","year":"2011","journal-title":"World J Emerg Med"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24021796","article-title":"The uPA\/uPAR system orchestrates the inflammatory response, vascular homeostasis, and immune system in fibrosis progression","volume":"24","author":"Kanno","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1046\/j.1538-7836.2003.00261.x","article-title":"Inflammation and thrombosis","volume":"1","author":"Esmon","year":"2003","journal-title":"J Thromb Haemost"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2014.151","article-title":"Inhibition of plasmin attenuates murine acute graft-versus-host disease mortality by suppressing the matrix metalloproteinase-9-dependent inflammatory cytokine storm and effector cell trafficking","volume":"29","author":"Sato","year":"2015","journal-title":"Leukemia"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-09-738096","article-title":"Pharmacological targeting of plasmin prevents lethality in a murine model of macrophage activation syndrome","volume":"130","author":"Shimazu","year":"2017","journal-title":"Blood"},{"key":"B33","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.cell.2020.11.025","article-title":"Synergism of TNF-\u03b1 and IFN-\u03b3 Triggers inflammatory cell death, tissue damage, and mortality in SARS-coV-2 infection and cytokine shock syndromes","volume":"184","author":"Karki","year":"2021","journal-title":"Cell"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1007\/s00392-020-01769-9","article-title":"Elevated markers of thrombo-inflammatory activation predict outcome in patients with cardiovascular comorbidities and COVID-19 disease: insights from the LEOSS registry","volume":"110","author":"Cremer","year":"2021","journal-title":"Clin Res Cardiol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-08-3176","article-title":"Increased soluble urokinase plasminogen activator receptor (suPAR) serum levels after granulocyte colony-stimulating factor treatment do not predict successful progenitor cell mobilization in vivo","volume":"107","author":"Fietz","year":"2006","journal-title":"Blood"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.15407\/biotech13.06.050","article-title":"Polyclonal antibodies against human plasminogen: purification, characterization and application","volume":"13","author":"Yatsenko","year":"2020","journal-title":"Biotechnologia Acta"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2021-0208ED","article-title":"The central role of PAI-1 in COVID-19: thrombosis and beyond","volume":"65","author":"Khan","year":"2021","journal-title":"Am J Respir Cell Mol Biol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020008951","article-title":"Plasminogen: an enigmatic zymogen","volume":"137","author":"Keragala","year":"2021","journal-title":"Blood"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2020-0544OC","article-title":"ZMPSTE24 regulates SARS-coV-2 spike protein-enhanced expression of endothelial PAI-1","volume":"65","author":"Han","year":"2021","journal-title":"Am J Respir Cell Mol Biol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.exphem.2008.06.016","article-title":"Increased soluble urokinase plasminogen activator receptor (suPAR) is associated with thrombosis and inhibition of plasmin generation in paroxysmal nocturnal hemoglobinuria (PNH) patients","volume":"36","author":"Sloand","year":"2008","journal-title":"Exp Hematol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.2010.01595.x","article-title":"Plasma concentrations of VCAM-1 and PAI-1: A predictive biomarker for post-operative recurrence in colorectal cancer","volume":"101","author":"Yamada","year":"2010","journal-title":"Cancer Sci"},{"key":"B42","doi-asserted-by":"publisher","first-page":"35483","DOI":"10.1038\/srep35483","article-title":"TGF-\u03b2 induces p53\/Smads complex formation in the PAI-1 promoter to activate transcription","volume":"6","author":"Kawarada","year":"2016","journal-title":"Sci Rep"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2020.10.001","article-title":"COVID-19-induced ARDS is associated with decreased frequency of activated memory\/effector T cells expressing CD11a++","volume":"28","author":"Anft","year":"2020","journal-title":"Mol Ther"},{"key":"B44","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1055\/s-0038-1649608","article-title":"Antigens of tissue plasminogen activator and plasminogen activator inhibitor 1: correlates in nonsmoking Japanese and Caucasian men and women","volume":"70","author":"Iso","year":"1993","journal-title":"Thromb Haemost"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/S0049-3848(09)70136-7","article-title":"Effects of race and ethnicity on the incidence of venous thromboembolism","author":"White","year":"2009","journal-title":"Thromb Res"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2011.04443.x","article-title":"Racial differences in venous thromboembolism","volume":"9","author":"Zakai","year":"2011","journal-title":"J Thromb Haemostasis"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1111\/jth.12464","article-title":"Incidence of venous thromboembolism in different ethnic groups: a regional direct comparison study","volume":"12","author":"Liao","year":"2014","journal-title":"J Thromb Haemostasis"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1007\/s11239-009-0365-8","article-title":"The role of ethnicity, age and gender in venous thromboembolism","volume":"29","author":"Montagnana","year":"2010","journal-title":"J Thromb Thrombolysis"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00312.2002","article-title":"Elevated levels of plasminogen activator inhibitor-1 in pulmonary edema fluid are associated with mortality in acute lung injury","volume":"285","author":"Prabhakaran","year":"2003","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1038\/s41598-020-80010-z","article-title":"Plasma tissue plasminogen activator and plasminogen activator inhibitor-1 in hospitalized COVID-19 patients","volume":"11","author":"Zuo","year":"2021","journal-title":"Sci Rep"},{"key":"B51","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s12985-022-01814-1","article-title":"COVID-19 infection: an overview on cytokine storm and related interventions","volume":"19","author":"Montazersaheb","year":"2022","journal-title":"Virol J"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1055\/s-0041-1742095","article-title":"The role of IL-6 in coronavirus, especially in COVID-19","volume":"13","author":"Wang","year":"2022","journal-title":"Front Pharmacol"},{"key":"B53","article-title":"In vivo modulation of coagulation and fibrinolysis by recombinant glycosylated human interleukin-6 in baboons","volume":"5","author":"Mestries","year":"1994","journal-title":"Eur Cytokine Netw"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-4658.2005.04979.x","article-title":"Induction of PAI-1 expression by tumor necrosis factor alpha in endothelial cells is mediated by its responsive element located in the 4G\/5G site","volume":"272","author":"Swiatkowska","year":"2005","journal-title":"FEBS J"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2004.12.007","article-title":"The complex between tPA and PAI-1: risk factor for myocardial infarction as studied in the SHEEP project","volume":"116","author":"Nordenhem","year":"2005","journal-title":"Thromb Res"},{"key":"B56","article-title":"Mosby\u2019s manual of diagnostic and laboratory tests (6th ed.)","author":"Pagana","year":"2017"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.jjcc.2022.03.015","article-title":"The current status of thrombosis and anticoagulation therapy in patients with COVID-19 in Japan: From the CLOT-COVID study","volume":"80","author":"Nishimoto","year":"2022","journal-title":"J Cardiol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2020.04.041","article-title":"Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: An updated analysis","volume":"191","author":"Klok","year":"2020","journal-title":"Thromb Res"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.5551\/jat.RPT001","article-title":"COVID-19-related thrombosis in Japan: final report of a questionnaire-based survey in 2020","volume":"28","author":"Horiuchi","year":"2021","journal-title":"J Atheroscl Thromb"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V87.9.3545.bloodjournal8793545","article-title":"Single-chain urokinase-type plasminogen activator bound to its receptor is relatively resistant to plasminogen activator inhibitor type 1","volume":"87","author":"Higazi","year":"1996","journal-title":"Blood"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199003293221304","article-title":"Depressed bronchoalveolar urokinase activity in patients with adult respiratory distress syndrome","volume":"322","author":"Bertozzi","year":"1990","journal-title":"N Engl J Med"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1055\/s-0039-1697953","article-title":"Urokinase plasminogen activator overexpression reverses established lung fibrosis","volume":"119","author":"Horowitz","year":"2019","journal-title":"Thromb Haemost"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1111\/jth.14844","article-title":"Pathological evidence of pulmonary thrombotic phenomena in severe COVID-19","volume":"18","author":"Dolhnikoff","year":"2020","journal-title":"J Thromb Haemost"},{"key":"B64","doi-asserted-by":"publisher","first-page":"e64330","DOI":"10.7554\/eLife.64330","article-title":"SARS-CoV-2 suppresses anticoagulant and fibrinolytic gene expression in the lung","volume":"10","author":"Mast","year":"2021","journal-title":"eLife"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-5793(01)02797-1","article-title":"PAI-1 inhibits urokinase-induced chemotaxis by internalizing the urokinase receptor","volume":"505","author":"Degryse","year":"2001","journal-title":"FEBS Lett"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.202013110","article-title":"uPA-PAI-1 heteromerization promotes breast cancer progression by attracting tumorigenic neutrophils","volume":"13","author":"Uhl","year":"2021","journal-title":"EMBO Mol Med"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1016\/j.febslet.2009.12.039","article-title":"The urokinase receptor: Focused cell surface proteolysis, cell adhesion and signaling","volume":"584","author":"Blasi","year":"2010","journal-title":"FEBS Lett"},{"key":"B68","doi-asserted-by":"publisher","first-page":"166170","DOI":"10.1016\/j.bbadis.2021.166170","article-title":"VCAM-1 as a predictor biomarker in cardiovascular disease","volume":"1867","author":"Troncoso","year":"2021","journal-title":"Biochim Biophys Acta (BBA) - Mol Basis Dis"}],"updated-by":[{"DOI":"10.3389\/fimmu.2024.1390698","type":"corrigendum","label":"Corrigendum","source":"publisher","updated":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T00:00:00Z","timestamp":1710288000000}}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1299792\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T07:46:21Z","timestamp":1710315981000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1299792\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,11]]},"references-count":68,"alternative-id":["10.3389\/fimmu.2023.1299792"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2023.1299792","relation":{"corrigendum":[{"id-type":"doi","id":"10.3389\/fimmu.2024.1390698","asserted-by":"object"}]},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,11]]},"article-number":"1299792"}}